Literature DB >> 26653081

Telomere maintenance is pivotal for high-risk neuroblastoma.

Falk Hertwig1,2, Martin Peifer2,3, Matthias Fischer1,2,4.   

Abstract

Entities:  

Keywords:  ATRX; MYCN; TERT; genetic etiology; neuroblastoma; rearrangement; telomere maintenance

Mesh：

Substances：

Year:  2015        PMID： 26653081      PMCID： PMC4943683          DOI： 10.1080/15384101.2015.1125243

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

2.  Telomerase activation by genomic rearrangements in high-risk neuroblastoma.

Authors:  Martin Peifer; Falk Hertwig; Frederik Roels; Daniel Dreidax; Moritz Gartlgruber; Roopika Menon; Andrea Krämer; Justin L Roncaioli; Frederik Sand; Johannes M Heuckmann; Fakhera Ikram; Rene Schmidt; Sandra Ackermann; Anne Engesser; Yvonne Kahlert; Wenzel Vogel; Janine Altmüller; Peter Nürnberg; Jean Thierry-Mieg; Danielle Thierry-Mieg; Aruljothi Mariappan; Stefanie Heynck; Erika Mariotti; Kai-Oliver Henrich; Christian Gloeckner; Graziella Bosco; Ivo Leuschner; Michal R Schweiger; Larissa Savelyeva; Simon C Watkins; Chunxuan Shao; Emma Bell; Thomas Höfer; Viktor Achter; Ulrich Lang; Jessica Theissen; Ruth Volland; Maral Saadati; Angelika Eggert; Bram de Wilde; Frank Berthold; Zhiyu Peng; Chen Zhao; Leming Shi; Monika Ortmann; Reinhard Büttner; Sven Perner; Barbara Hero; Alexander Schramm; Johannes H Schulte; Carl Herrmann; Roderick J O'Sullivan; Frank Westermann; Roman K Thomas; Matthias Fischer
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

3.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

Authors:  Nai-Kong V Cheung; Jinghui Zhang; Charles Lu; Matthew Parker; Armita Bahrami; Satish K Tickoo; Adriana Heguy; Alberto S Pappo; Sara Federico; James Dalton; Irene Y Cheung; Li Ding; Robert Fulton; Jianmin Wang; Xiang Chen; Jared Becksfort; Jianrong Wu; Catherine A Billups; David Ellison; Elaine R Mardis; Richard K Wilson; James R Downing; Michael A Dyer
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

4.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

5.  TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.

Authors:  Linda J Valentijn; Jan Koster; Danny A Zwijnenburg; Nancy E Hasselt; Peter van Sluis; Richard Volckmann; Max M van Noesel; Rani E George; Godelieve A M Tytgat; Jan J Molenaar; Rogier Versteeg
Journal:  Nat Genet       Date:  2015-11-02       Impact factor: 38.330

6.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.

Authors:  Mark Sausen; Rebecca J Leary; Siân Jones; Jian Wu; C Patrick Reynolds; Xueyuan Liu; Amanda Blackford; Giovanni Parmigiani; Luis A Diaz; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Michael D Hogarty
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

7.  The genetic landscape of high-risk neuroblastoma.

Authors:  Trevor J Pugh; Olena Morozova; Edward F Attiyeh; Shahab Asgharzadeh; Jun S Wei; Daniel Auclair; Scott L Carter; Kristian Cibulskis; Megan Hanna; Adam Kiezun; Jaegil Kim; Michael S Lawrence; Lee Lichenstein; Aaron McKenna; Chandra Sekhar Pedamallu; Alex H Ramos; Erica Shefler; Andrey Sivachenko; Carrie Sougnez; Chip Stewart; Adrian Ally; Inanc Birol; Readman Chiu; Richard D Corbett; Martin Hirst; Shaun D Jackman; Baljit Kamoh; Alireza Hadj Khodabakshi; Martin Krzywinski; Allan Lo; Richard A Moore; Karen L Mungall; Jenny Qian; Angela Tam; Nina Thiessen; Yongjun Zhao; Kristina A Cole; Maura Diamond; Sharon J Diskin; Yael P Mosse; Andrew C Wood; Lingyun Ji; Richard Sposto; Thomas Badgett; Wendy B London; Yvonne Moyer; Julie M Gastier-Foster; Malcolm A Smith; Jaime M Guidry Auvil; Daniela S Gerhard; Michael D Hogarty; Steven J M Jones; Eric S Lander; Stacey B Gabriel; Gad Getz; Robert C Seeger; Javed Khan; Marco A Marra; Matthew Meyerson; John M Maris
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330
  7 in total
  13 in total

1.  Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait.

Authors:  Anneleen Decock; Maté Ongenaert; Bram De Wilde; Bénédicte Brichard; Rosa Noguera; Frank Speleman; Jo Vandesompele
Journal:  Epigenetics       Date:  2016-10-02       Impact factor: 4.528

2.  Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.

Authors:  Balakrishna Koneru; Gonzalo Lopez; Ahsan Farooqi; Karina L Conkrite; Thinh H Nguyen; Shawn J Macha; Apexa Modi; Jo Lynne Rokita; Eduardo Urias; Ashly Hindle; Heather Davidson; Kristyn Mccoy; Jonas Nance; Vanda Yazdani; Meredith S Irwin; Shengping Yang; David A Wheeler; John M Maris; Sharon J Diskin; C Patrick Reynolds
Journal:  Cancer Res       Date:  2020-04-14       Impact factor: 12.701

Review 3.  Chromatin Bottlenecks in Cancer.

Authors:  Jay F Sarthy; Steven Henikoff; Kami Ahmad
Journal:  Trends Cancer       Date:  2019-02-26

4.  Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma.

Authors:  Eun Young Yu; Irene Y Cheung; Yi Feng; Mohamed O Rabie; Gail J Roboz; Monica L Guzman; Nai-Kong V Cheung; Neal F Lue
Journal:  Neoplasia       Date:  2019-05-23       Impact factor: 5.715

5.  Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Authors:  Meredith S Irwin; Arlene Naranjo; Fan F Zhang; Susan L Cohn; Wendy B London; Julie M Gastier-Foster; Nilsa C Ramirez; Ruthann Pfau; Shalini Reshmi; Elizabeth Wagner; Jed Nuchtern; Shahab Asgharzadeh; Hiroyuki Shimada; John M Maris; Rochelle Bagatell; Julie R Park; Michael D Hogarty
Journal:  J Clin Oncol       Date:  2021-07-28       Impact factor: 50.717

6.  Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.

Authors:  Elisa Izquierdo; Lina Yuan; Sally George; Michael Hubank; Chris Jones; Paula Proszek; Janet Shipley; Susanne A Gatz; Caedyn Stinson; Andrew S Moore; Steven C Clifford; Debbie Hicks; Janet C Lindsey; Rebecca M Hill; Thomas S Jacques; Jane Chalker; Khin Thway; Simon O'Connor; Lynley Marshall; Lucas Moreno; Andrew Pearson; Louis Chesler; Brian A Walker; David Gonzalez De Castro
Journal:  Oncotarget       Date:  2017-12-06

Review 7.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

Review 8.  Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.

Authors:  S L George; V Parmar; F Lorenzi; L V Marshall; Y Jamin; E Poon; P Angelini; L Chesler
Journal:  J Exp Clin Cancer Res       Date:  2020-05-06

Review 9.  Telomere Maintenance in Pediatric Cancer.

Authors:  Sandra Ackermann; Matthias Fischer
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

10.  Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.

Authors:  Samuel W Brady; Yanling Liu; Xiaotu Ma; Alexander M Gout; Kohei Hagiwara; Xin Zhou; Jian Wang; Michael Macias; Xiaolong Chen; John Easton; Heather L Mulder; Michael Rusch; Lu Wang; Joy Nakitandwe; Shaohua Lei; Eric M Davis; Arlene Naranjo; Cheng Cheng; John M Maris; James R Downing; Nai-Kong V Cheung; Michael D Hogarty; Michael A Dyer; Jinghui Zhang
Journal:  Nat Commun       Date:  2020-10-14       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.